Alto Neuroscience (ANRO) News Today $4.09 +0.27 (+7.07%) Closing price 09/18/2025 03:59 PM EasternExtended Trading$4.09 +0.00 (+0.10%) As of 09/18/2025 07:50 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Why Is Alto Neuroscience Up Today?Toggle Visibility of Why Is Alto Neuroscience Up Today?Alto Neuroscience, Inc. (NYSE: ANRO) is trading higher today, but investors should be aware of an increasing number of securities class action notices and deadline reminders tied to alleged misrepresentations around its February 2024 IPO and subsequent disclosures. Multiple law firms are urging shareholders who bought ANRO stock between February 2, 2024 and October 22, 2024 to file lead plaintiff motions before the September 19, 2025 deadline, creating potential legal overhang for the stock. Negative Sentiment: Bragar Eagel & Squire, P.C. reminds investors of the September 19, 2025 deadline to discuss legal options if they suffered losses in Alto Neuroscience (ANRO). ANRO FINAL DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors in Alto Neuroscience, Inc. (ANRO) of the September 19th Deadline Negative Sentiment: Levi & Korsinsky urges Alto Neuroscience shareholders to protect their rights and contact the firm before the September 19, 2025 lead plaintiff deadline. Investors in Alto Neuroscience, Inc. (ANRO): Protect Your Rights – Contact Levi & Korsinsky Before September 19, 2025 Negative Sentiment: Faruqi & Faruqi reminds investors of the pending class action against Alto with a September 19, 2025 deadline to serve as lead plaintiff. Faruqi & Faruqi Reminds Alto Neuroscience Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of September 19, 2025 - ANRO Negative Sentiment: The Gross Law Firm issues a notice to Alto Neuroscience shareholders about the September 19, 2025 deadline to join a class action suit. September 19, 2025 Deadline: Contact The Gross Law Firm to Join Class Action Suit Against ANRO Negative Sentiment: Bronstein, Gewirtz & Grossman LLC notifies Alto Neuroscience investors of a class action filing and opportunity to lead the lawsuit. ANRO INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Alto Neuroscience, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit Negative Sentiment: Portnoy Law Firm reminds shareholders of the September 19, 2025 deadline to file a lead plaintiff motion in the Alto class action. Alto Neuroscience, Inc. Investors: Please contact the Portnoy Law Firm to recover your losses. September 19, 2025 Deadline to file Lead Plaintiff Motion. Negative Sentiment: Pomerantz LLP announces the filing of a class action against Alto and certain officers, inviting investors to participate. Pomerantz Law Firm Announces the Filing of a Class Action Against Alto Neuroscience, Inc. and Certain Officers - ANRO Negative Sentiment: The Gross Law Firm issues another reminder on the pending class action and September 19, 2025 deadline. The Gross Law Firm Reminds Alto Neuroscience, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of September 19, 2025 - ANRO Negative Sentiment: The Schall Law Firm announces its filing of a securities fraud class action against Alto, with a September 19, 2025 lead plaintiff deadline. ANRO Investors Have Opportunity to Lead Alto Neuroscience, Inc. Securities Fraud Lawsuit with the Schall Law Firm Negative Sentiment: The DJS Law Group reminds investors of a class action against Alto Neuroscience for securities law violations and the approaching deadline. Alto Neuroscience, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - ANRO Posted 29m agoAI Generated. May Contain Errors. ANRO Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 Time Period ANRO FINAL DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors in Alto Neuroscience, Inc. (ANRO) of the September 19th Deadline1 hour ago | globenewswire.comFaruqi & Faruqi Reminds Alto Neuroscience Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of September 19, 2025 - ANROSeptember 18 at 6:37 PM | prnewswire.comSeptember 19, 2025 Deadline: Contact The Gross Law Firm to Join Class Action Suit Against ANROSeptember 18 at 4:45 PM | globenewswire.comANRO INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Alto Neuroscience, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action LawsuitSeptember 18 at 4:00 PM | globenewswire.comAlto Neuroscience, Inc. Investors: Please contact the Portnoy Law Firm to recover your losses. September 19, 2025 Deadline to file Lead Plaintiff Motion.September 18 at 1:32 PM | globenewswire.comPomerantz Law Firm Announces the Filing of a Class Action Against Alto Neuroscience, Inc. and Certain Officers - ANROSeptember 18 at 10:00 AM | prnewswire.comThe Gross Law Firm Reminds Alto Neuroscience, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of September 19, 2025 - ANROSeptember 18 at 8:45 AM | prnewswire.comANRO Investors Have Opportunity to Lead Alto Neuroscience, Inc. Securities Fraud Lawsuit with the Schall Law FirmSeptember 18 at 3:21 AM | prnewswire.comAlto Neuroscience, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - ANROSeptember 18 at 3:20 AM | prnewswire.comDEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Alto NeuroscienceSeptember 17 at 11:40 PM | globenewswire.comANRO Deadline: ANRO Investors Have Opportunity to Lead Alto Neuroscience, Inc. Securities Fraud LawsuitSeptember 17 at 6:32 PM | prnewswire.comANRO DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors in Alto Neuroscience, Inc. (ANRO) of the September 19th DeadlineSeptember 17 at 5:46 PM | globenewswire.comANRO LAWSUIT ALERT: Levi & Korsinsky Notifies Alto Neuroscience, Inc. Investors of a Class Action Lawsuit and Upcoming DeadlineSeptember 16 at 5:18 PM | globenewswire.comAlto Neuroscience, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - ANROSeptember 16 at 8:45 AM | prnewswire.comANRO DEADLINE: ROSEN, NATIONAL TRIAL LAWYERS, Encourages Alto Neuroscience, Inc. Investors to Secure Counsel Before Important September 19 Deadline in Securities Class Action - ANROSeptember 15, 2025 | globenewswire.comAlto Neuroscience, Inc. Class Action: The Gross Law Firm Reminds Alto Neuroscience, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of September 19, 2025 – ANROSeptember 15, 2025 | globenewswire.comContact The Gross Law Firm by September 19, 2025 Deadline to Join Class Action Against Alto Neuroscience, Inc.(ANRO)September 15, 2025 | prnewswire.comALTO NEUROSCIENCE DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Alto Neuroscience, Inc. (ANRO) and Encourages Investors to Contact the FirmSeptember 15, 2025 | globenewswire.comSCS Capital Management LLC Takes $144,000 Position in Alto Neuroscience, Inc. $ANROSeptember 15, 2025 | marketbeat.comAlto Neuroscience, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - ANROSeptember 15, 2025 | prnewswire.comANRO Investors Have Opportunity to Lead Alto Neuroscience, Inc. Securities Fraud Lawsuit with the Schall Law FirmSeptember 15, 2025 | prnewswire.comBrokerages Set Alto Neuroscience, Inc. (NYSE:ANRO) Target Price at $8.50September 15, 2025 | americanbankingnews.comANRO INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Alto Neuroscience, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action LawsuitSeptember 14, 2025 | globenewswire.comPomerantz Law Firm Announces the Filing of a Class Action Against Alto Neuroscience, Inc.and Certain Officers – ANROSeptember 14, 2025 | globenewswire.comAlto Neuroscience, Inc. (NYSE:ANRO) Given Average Rating of "Moderate Buy" by AnalystsSeptember 14, 2025 | marketbeat.comANRO Deadline: Rosen Law Firm Urges Alto Neuroscience, Inc. (NYSE: ANRO) Stockholders to Contact the Firm for Information About Their RightsSeptember 13, 2025 | businesswire.comINVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Alto NeuroscienceSeptember 13, 2025 | prnewswire.comPomerantz Law Firm Announces the Filing of a Class Action Against Alto Neuroscience, Inc. and Certain Officers - ANROSeptember 13, 2025 | prnewswire.comANRO Deadline: ANRO Investors Have Opportunity to Lead Alto Neuroscience, Inc. Securities Fraud LawsuitSeptember 12, 2025 | prnewswire.comANRO DEADLINE NOTICE: ROSEN, A LEADING LAW FIRM, Encourages Alto Neuroscience, Inc. Investors to Secure Counsel Before Important September 19 Deadline in Securities Class Action - ANROSeptember 12, 2025 | globenewswire.comShareholders of Alto Neuroscience, Inc. Should Contact Levi & Korsinsky Before September 19, 2025 to Discuss Your Rights - ANROSeptember 12, 2025 | prnewswire.comFaruqi & Faruqi Reminds Alto Neuroscience Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of September 19, 2025 - ANROSeptember 11, 2025 | globenewswire.comContact Levi & Korsinsky by September 19, 2025 Deadline to Join Class Action Against Alto Neuroscience, Inc. (ANRO)September 11, 2025 | globenewswire.comShareholders that lost money on Alto Neuroscience, Inc.(ANRO) should contact The Gross Law Firm about pending Class Action - ANROSeptember 11, 2025 | prnewswire.comALTO NEUROSCIENCE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Alto Neuroscience, Inc. (ANRO) and Encourages Investors to Contact the FirmSeptember 11, 2025 | globenewswire.comAlto Neuroscience, Inc. Sued for Securities Law Violations – Investors Should Contact The Gross Law Firm Before September 19, 2025 to Discuss Your Rights – ANROSeptember 10, 2025 | globenewswire.comPomerantz Law Firm Announces the Filing of a Class Action Against Alto Neuroscience, Inc.and Certain Officers – ANROSeptember 10, 2025 | globenewswire.comAlto Neuroscience announces results from replication studySeptember 9, 2025 | msn.comANRO IMPORTANT DEADLINE: ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Alto Neuroscience, Inc. Investors to Secure Counsel Before Important September 19 Deadline in Securities Class Action - ANROSeptember 9, 2025 | globenewswire.comANRO Deadline: ANRO Investors Have Opportunity to Lead Alto Neuroscience, Inc. Securities Fraud LawsuitSeptember 9, 2025 | prnewswire.comINVESTOR ALERT: Holzer & Holzer, LLC Reminds Investors of September 19, 2025 Lead Plaintiff Deadline in the Alto Neuroscience, Inc. (ANRO) Class Action – Investors With Significant Losses Encouraged to Contact the FirmSeptember 9, 2025 | globenewswire.comKuehn Law Encourages Investors of Alto Neuroscience, Inc. to Contact Law FirmSeptember 9, 2025 | markets.businessinsider.comINVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Alto NeuroscienceSeptember 9, 2025 | businesswire.comLevi & Korsinsky Reminds Alto Neuroscience, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of September 19, 2025 - ANROSeptember 9, 2025 | prnewswire.comAlto Neuroscience Announces Robust Replication of EEG Biomarker to Objectively Identify Patients with Cognitive Impairment in SchizophreniaSeptember 9, 2025 | businesswire.comInvestors who lost money on Alto Neuroscience, Inc. (ANRO) should contact Levi & Korsinsky about pending Class Action - ANROSeptember 8, 2025 | globenewswire.comANRO INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Alto Neuroscience, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action LawsuitSeptember 8, 2025 | globenewswire.comAlto Neuroscience, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - ANROSeptember 8, 2025 | prnewswire.comPomerantz Law Firm Announces the Filing of a Class Action Against Alto Neuroscience, Inc. and Certain Officers - ANROSeptember 8, 2025 | prnewswire.comANRO Investors Have Opportunity to Lead Alto Neuroscience, Inc. Securities Fraud Lawsuit with the Schall Law FirmSeptember 8, 2025 | prnewswire.com Get Alto Neuroscience News Delivered to You Automatically Sign up to receive the latest news and ratings for ANRO and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. ANRO Media Mentions By Week ANRO Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ANRO News Sentiment▼0.100.68▲Average Medical News Sentiment ANRO News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ANRO Articles This Week▼307▲ANRO Articles Average Week Get the Latest News and Ratings for ANRO and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Alto Neuroscience and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies PureTech Health News Today Y-mAbs Therapeutics News Today Autolus Therapeutics News Today Zhengye Biotechnology News Today CytomX Therapeutics News Today Design Therapeutics News Today Benitec Biopharma News Today I-Mab News Today Upexi News Today Rocket Pharmaceuticals News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:ANRO) was last updated on 9/19/2025 by MarketBeat.com Staff From Our PartnersHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredA New Way to Double Your Retirement Income?Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boo...Investors Alley | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredStrange crypto pattern discovered by 40-person research teamSomething unusual is happening inside a 40-person crypto research firm. They're helping 8,000+ ordinary peo...Crypto Swap Profits | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | SponsoredCrypto Gets Official Government Backing—Here's the WinnerTrump Just Signed the GENIUS Act—One Coin is About to Explode We're at the BEGINNING of smart money really ...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Alto Neuroscience, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Alto Neuroscience With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ANRO Stock Alerts